Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.431,03
0,66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Theriva Biologics Inc (TOVX) Theriva Biologics Inc (TOVX) Notizie

Theriva Biologics Inc

TOVX
1,29
0,01 (0,78%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202422:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/11/202414:10EDGAR2Form 8-K - Current report
01/11/202421:05EDGAR2Form 8-K - Current report
16/10/202414:10EDGAR2Form 8-K - Current report
03/10/202422:12EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
03/10/202414:10EDGAR2Form 8-K - Current report
02/10/202416:53EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
30/9/202423:13EDGAR2Form DEF 14A - Other definitive proxy statements
27/9/202421:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/9/202422:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/9/202414:20EDGAR2Form S-1/A - General form for registration of securities..
23/9/202414:10EDGAR2Form 8-K - Current report
18/9/202423:06EDGAR2Form PRE 14A - Other preliminary proxy statements
16/9/202414:10EDGAR2Form 8-K - Current report
11/9/202414:45EDGAR2Form S-3/A - Registration statement under Securities Act of..
10/9/202423:03EDGAR2Form S-1 - General form for registration of securities under..
09/9/202423:11EDGAR2Form 8-K - Current report
26/8/202414:22EDGAR2Form 8-K - Current report
16/8/202422:21EDGAR2Form 8-K - Current report
13/8/202414:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:05EDGAR2Form 8-K - Current report
31/7/202414:20EDGAR2Form 8-K - Current report
23/5/202414:20EDGAR2Form 8-K - Current report
16/5/202413:30EDGAR2Form 8-K - Current report
07/5/202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:05EDGAR2Form 8-K - Current report
07/2/202414:10EDGAR2Form 8-K - Current report
08/1/202414:10EDGAR2Form 8-K - Current report
15/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,30 Min: 1,27 Max: 1,32
Chiusura: 1,28

La tua Cronologia

AMEX
TOVX
Theriva Biologics
TG
GIQA
Mori Capital Management
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network